COYA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Coya Therapeutics Inc (COYA) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The lack of positive financial performance, weak technical indicators, and absence of significant trading trends or catalysts suggest that this stock is better suited for monitoring rather than immediate investment.
The MACD is slightly positive but contracting, RSI is neutral at 41.876, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 4.83, with support at 4.652 and resistance at 5.007, suggesting limited short-term price movement.
NULL identified. No recent news, no significant insider or hedge fund activity, and no recent congress trading data.
Negative financial performance in Q3 2025, with a 47.39% YoY decline in net income and a 50% YoY drop in EPS. The stock also experienced a -3.65% regular market change and a -4.06% pre-market change.
In Q3 2025, revenue remained flat YoY at $3,564,254, but net income dropped significantly to -$2,115,831 (-47.39% YoY), and EPS fell to -0.13 (-50% YoY). Gross margin remained at 100%.
No analyst rating or price target data provided.
